Benoît You

12.6k citations
263 papers · 9.0k · 5 hit papers · h-index 43

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 0.5%
    • PARP inhibition in cancer therapy
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Ovarian cancer diagnosis and treatment 54
    • PARP inhibition in cancer therapy 35
    • Cancer Treatment and Pharmacology 13
    • Cancer Immunotherapy and Biomarkers 11

Benoît You

248 papers receiving 8.8k citations

Benoît You's Hit Papers

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial 2023 · 226 citations
2260+3+6Years since publication50010001.5k

Peers

Benoît You
Comparison fields: 5 of 132
  • Reproductive Medicine 1.9k
  • Oncology 4.3k
  • Cancer Research 860
  • Obstetrics and Gynecology 426
  • Immunology 649
Replace Gilles Freyer with:
Gilles Freyer France
Paul J. Sabbatini United States
Francesco Perrone Italy
Saverio Cinieri Italy
Alain H. Lortholary France
Manuel Jorge Rodrigues France
Jean‐Paul Guastalla France
Timothy John Perren United Kingdom
Jean‐Pierre Lotz France
Paul R. Harnett Australia
Benoît You relative to Gilles Freyer France Gilles Freyer's profile →
Citations per field
00.5×1.5×2.1×
Gilles Freyer · 1×
Citations per year

Countries citing papers authored by Benoît You

Since Specialization
Citations

This map shows the geographic impact of Benoît You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît You more than expected).

Fields of papers citing papers by Benoît You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît You. The network helps show where Benoît You may publish in the future.

Co-authors

The 25 scholars most cited alongside Benoît You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benoît You Line = papers co-authored together Benoît You links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Hit paper breakdown →
20191510
2
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
20171394
3
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
Hit paper breakdown →
2020380
4 2016236
5
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Hit paper breakdown →
2023226
6 2019199
7 2020151
8 2019148
9
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2023147
10 2016142
11 2017132
12 2021127
13 2022121
14 2014104
15 201197
16 201392
17 202090
18 202087
19 201684
20 201282

About Benoît You

Benoît You is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 263 papers that have together received 9.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (54 papers), PARP inhibition in cancer therapy (35 papers), Gestational Trophoblastic Disease Studies (32 papers), Intraperitoneal and Appendiceal Malignancies (28 papers), Endometrial and Cervical Cancer Treatments (18 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Treatment and Pharmacology (13 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Reproductive Medicine (1.9k citations), Oncology (4.3k citations), Cancer Research (860 citations), Obstetrics and Gynecology (426 citations) and Immunology (649 citations). Benoît You has collaborated with scholars based in France, United States and India. Frequent co-authors include Gilles Freyer, Hui Kong Gan, Julien Péron, Denis Maillet, Eric Xueyu Chen, Michel Tod, Gregory R. Pond, Olivier Colomban, Olivier Gléhen and François Golfier. Their work appears in journals such as Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, European Journal of Cancer and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact